If doctors could catch the first signs of Alzheimer’s disease in the brain earlier, could the disease be delayed or even prevented?
This is the question that researchers at Duke and UNC are hoping to answer by joining forces on an ambitious new program called the Alzheimer’s Disease Research Collaborative (ADRC). The Duke-UNC collaborative includes experts from a dozen disciplines, from neurology to bioinformatics to pathology.
James Carter, Sr.’s love for reading, science and medicine blossomed when he was a young boy in Maysville, North Carolina, as he pored over the scientific magazines his mother regularly brought him from the doctor’s home where she was a housekeeper. Sharing these magazines with her son was just one of the ways Irene Carter reinforced the importance of education to her four children, and this simple act undoubtedly helped lay a foundation for his successful career as a physician.
Have you ever wondered how physicians determine the amount of medication that is safe and most effective for a child? Duke physician-scientist and critical care pediatrician Kanecia Zimmerman’s research has focused on that exact quandary— appropriate and correct doses of medications for children. She is no stranger to seeking answers to new and challenging questions to help the youngest members of society.
The COVID-19 pandemic has wreaked havoc in every part of American life, but it has taken a disproportionately heavy toll on people of color, including the Latinx community. By June 2020, Latinx people in North Carolina accounted for more than 40 percent of the state’s cases, despite comprising just 10 percent of the population, and they continue to be over-represented at the start of 2021, accounting for 23 percent of new cases, according to the North Carolina Department of Health and Human Services.